Lifeboat Foundation

Data captured and fed into an AI model should be used to shape and inform marketing programs for the betterment of the customer’s experience. Such a practice enables marketers to utilize valuable information but doesn’t put data privacy at risk. Humans maintain control and can add their own handprint to AI-generated content to develop something much more meaningful that resonates with targeted audiences. Within that construct, marketers must bring the heart and the emotional intelligence to generative AI if they want to maximize its potential while maintaining ethical boundaries.

Human-connected generative AI is poised to be the ultimate tool if used responsibly. It can recognize patterns and insights and develop recommendations for actions, effectively making workers smarter and better at their jobs.

Most businesses see generative AI’s capabilities as opportunities to do more with less. Now it’s time to take the next step forward, connecting data insights with personalized content to ethically move through the pipeline at a new level of speed and efficiency—and in a manner that’s rewarding and enriching for customers.

Some best practices for longevity can be a real bummer. Everyone knows that regular exercise is good for them, but not everyone enjoys it. Eating a few cups of veggies with every meal may not be as fun as a side of fries.

But every so often, the things that are good for us feel good too. Case in point: the humble massage.

A massage for most people is a spa-day splurge, but it’s also an ancient medicinal practice. A thorough rub-down is a great way to celebrate the end of a stressful semester, but there’s more to it than much-deserved relaxation. At its best, a good massage improves bodily motion and function. While science doesn’t say that each massage adds years to your life (not yet, anyway), the benefits of regular massages (for those lucky enough to get them) can add up over time.

We’re not at the scope of usage Cameron is anxious about yet, but we don’t have to imagine what AI’s role in the military could look like hypothetically—it’s already starting to happen. The U.S. Department of Defense is already investigating moves to create an archive of military data to use as part of what it sees as an escalating digital arms race with other nations, and the eventual weaponization of such technology. Not that Cameron himself hasn’t already thought about that extensively in his own filmmaking career already, of course.

“I warned you guys in 1984 and you didn’t listen,” the director not-so-jokingly added. But you know, hopefully we get protections for actors, writers, directors, and other creatives against generative AI replacements before we have to worry too much about someone making Skynet. Hopefully.

I gotta admit although effective and innovative, it’s also kinda creepy.

Last year, Monash University scientists created the “DishBrain” – a semi-biological computer chip with some 800,000 human and mouse brain cells lab-grown into its electrodes. Demonstrating something like sentience, it learned to play Pong within five minutes.

The micro-electrode array at the heart of the DishBrain was capable both of reading activity in the brain cells, and stimulating them with electrical signals, so the research team set up a version of Pong where the brain cells were fed a moving electrical stimulus to represent which side of the “screen” the ball was on, and how far away from the paddle it was. They allowed the brain cells to act on the paddle, moving it left and right.

Continue reading “Computer chip with built-in human brain tissue gets military funding” »

Triple-negative breast cancer is a combative cancer type with a highly inflated histological grade that leads to poor theragnostic value. Gene, protein, and receptor-specific targets have shown effective clinical outcomes in patients with TNBC. Cells are frequently exposed to DNA-damaging agents. DNA damage is repaired by multiple pathways; accumulations of mutations occur due to damage to one or more pathways and lead to alterations in normal cellular mechanisms, which lead to development of tumors. Advances in target-specific cancer therapies have shown significant momentum; most treatment options cause off-target toxicity and side effects on healthy tissues.

Novel Harm Reduction Strategies For The Opioid Epidemic — Harmguard FX — Jermonica Boardley & Joseph Scrocco — Sivad Group LLC / Diagnostic Solutions Group

Jermonica Boardley is President and CEO of SIVAD Diagnostic Medical Group LLC (https://sivadppe.com/), a minority-owned company dedicated to addressing the unique needs of underserved and unserved communities in the United States and globally, which most recently announced the launch of HarmGuard FX (https://www.harmstopper.com/), a single, low-cost strip that provides an affordable, reliable way for people to test substances for fentanyl and xylazine (popularly known as tranq), two dangerous adulterants that are exacerbating the already critical opioid epidemic.

Continue reading “Jermonica Boardley & Joseph Scrocco — Novel Harm Reduction Strategies For The Opioid Epidemic” »

Alex’s lemonade stand foundation — fighting childhood cancer, one cup at a time! liz scott, co-executive director, alex’s lemonade stand foundation.

Liz Scott is Co-Executive Director, of Alex’s Lemonade Stand Foundation for Childhood Cancer (ALSF — https://www.alexslemonade.org/), an organization which emerged from the front yard lemonade stand of her daughter, Alexandra “Alex” Scott (1996−2004).

Continue reading “Liz Scott, Co-Executive Director, Alex’s Lemonade Stand Foundation for Childhood Cancer” »

Sci-fi writers and AI researchers worry: What happens if technology, specifically artificial intelligence, reaches singularity?

In March 2020, an experiment in science philanthropy was hatched in the span of a five-minute call.

Patrick Collison, the now 34-year-old billionaire CEO of the online payments company Stripe, and economist Tyler Cowen were chewing over a shared concern: Scientific progress seemed to be slowing down. As the first pandemic lockdowns went into effect, researchers were in a holding pattern, waiting to hear if they could redirect their federal grants to COVID-related work. Collison and Cowen worried that the National Institutes of Health wasn’t moving quickly enough, so they launched Fast Grants to get emergency research dollars to virologists, coronavirus experts, and other scientists rapidly.

“We thought: Let’s just do this,” Cowen recalls. “It was a bit like put up or shut up.”